HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsushi Takita Selected Research

Dermatitis

1/2022D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsushi Takita Research Topics

Disease

39Hemorrhage
03/2024 - 11/2015
39Atrial Fibrillation
02/2024 - 01/2019
19Stroke (Strokes)
01/2024 - 08/2017
8Ischemic Stroke
10/2023 - 01/2020
7Heart Failure
01/2024 - 12/2020
5Neoplasms (Cancer)
03/2024 - 08/2017
4Embolism (Embolus)
01/2024 - 01/2022
4Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2023 - 01/2022
2Venous Thromboembolism
03/2024 - 04/2017
2Transient Ischemic Attack
03/2024 - 01/2020
2Diabetes Mellitus
02/2024 - 12/2023
2Body Weight (Weight, Body)
11/2022 - 11/2020
2Rheumatoid Arthritis
02/2022 - 02/2022
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 04/2017
2Chronic Renal Insufficiency
12/2020 - 10/2020
2Renal Hypertension
04/2018 - 08/2017
1Cerebral Infarction
03/2024
1Dementia (Dementias)
11/2023
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2023
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
10/2023
1Myocardial Infarction
08/2023
1Thrombotic Stroke
01/2023
1Cardiomyopathies (Cardiomyopathy)
01/2023
1Stomach Neoplasms (Stomach Cancer)
01/2023
1Embolic Stroke
01/2023
1Frailty
07/2022
1Osteoporosis
02/2022
1Dermatitis
01/2022
1Thromboembolism
02/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2021
1Masked Hypertension
01/2021
1Anemia
12/2020
1Thrombosis (Thrombus)
12/2020
1Hemorrhagic Stroke
01/2020
1Pain (Aches)
11/2019
1Liver Failure
08/2017
1Pulmonary Embolism
04/2017
1Rupture
04/2017
1Acute Coronary Syndrome
11/2015
1Cystitis
12/2012
1Urinary Tract Infections (Urinary Tract Infection)
12/2012
1Infections
10/2011

Drug/Important Bio-Agent (IBA)

32AnticoagulantsIBA
02/2024 - 08/2017
18Warfarin (Coumadin)FDA LinkGeneric
01/2024 - 01/2020
9edoxabanIBA
11/2023 - 12/2019
8Prasugrel HydrochlorideFDA Link
01/2023 - 11/2015
5CreatinineIBA
11/2023 - 11/2020
4fibrin fragment D (D-dimer)IBA
03/2024 - 01/2022
4Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
02/2024 - 11/2015
4Biomarkers (Surrogate Marker)IBA
08/2023 - 02/2021
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 12/2020
3Proton Pump InhibitorsIBA
01/2020 - 08/2017
2Indicators and Reagents (Reagents)IBA
11/2023 - 12/2019
2Clopidogrel (Plavix)FDA Link
01/2023 - 11/2015
2DenosumabFDA Link
02/2022 - 02/2022
2Anti-Bacterial Agents (Antibiotics)IBA
12/2012 - 10/2011
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2024
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2023
1Heparin (Liquaemin)FDA LinkGeneric
12/2022
1vinyltriethoxysilane (VTES)IBA
01/2022
1Factor Xa InhibitorsIBA
01/2021
1N- (5- (2- bromobenzyl)thiazole- 2- yl)benzofuran- 2- carboxamideIBA
01/2020
1Analgesics (Analgesic Drugs)IBA
11/2019
1sitafloxacinIBA
12/2012

Therapy/Procedure

24Therapeutics
01/2024 - 11/2015
12Percutaneous Coronary Intervention
06/2022 - 11/2015
8Catheter Ablation
11/2023 - 11/2020
3Polypharmacy
01/2024 - 12/2022
3Stents
06/2022 - 12/2020
2Drug Therapy (Chemotherapy)
01/2023 - 08/2017
2Drug-Eluting Stents
01/2022 - 01/2022
1Secondary Prevention
01/2023
1Knee Replacement Arthroplasty (Total Knee Replacement)
04/2017
1Hip Replacement Arthroplasty (Total Hip Replacement)
04/2017
1Orthopedic Procedures
04/2017
1Aftercare (After-Treatment)
11/2015